Clinical Profile of Patients with Cancer and Human Immuno-Deficiency Infection, Cross-Sectional Observation Study from a Tertiary Care Cancer Center
Indian Journal of Medical and Paediatric Oncology · 01.02.2026 · 47 (01) · A01-A58
DOI: 10.1055/s-0046-1818484 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 01.02.2026. Verfasst von M. Kandula und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Anti-retroviral therapy has transformed human Immunodeficiency virus infection (HIV) into a manageable chronic condition. The overall profile of cancers in HIV patients evolved with AIDS-defining cancers (ADC) declining and non-ADC remaining constant. Aims and Objectives: We undertook a prospective cross-sectional observational study with the primary objective to identify the proportion of ADC among total cancers in HIV-infected patients. The secondary objectives were to describe the mean duration of HIV before cancer diagnosis and mean CD4 count in ADC and NADC. Materials and Methods: Study subjects included a successive series of HIV-positive patients diagnosed with cancer at our center between Jan 2023 and Aug 2024. Relevant clinical information was extracted from electronic medical records.
Results
In the study period, 151 patients were diagnosed with HIV and cancer. The median age was 48 years (SD: 10.1, 19–75). Majority were female (72.19%). Most common cancers were cervix (30.4%), hematolymphoid (17.2%), and breast (17.2%). ADC contributed to 45% of all cancers (68 total, 46 cervical and 22 NHL). Among the NADC, common cancers were breast (17.2%), lung (7.9%), and rectum (3.3%). At diagnosis, 31.1% were metastatic. At cancer diagnosis 21.1% were newly diagnosed with HIV infection. Among those with a prior history of HIV, 86.5% were on HAART and the median duration of HIV infection prior to cancer diagnoses was 6 years (SD 6.49, range 0.08–22). CD4 count was available at cancer diagnosis for 36%. Mean CD4 count at cancer diagnoses in ADC and NADC were 392 and 449 cells/µL, respectively Conclusion: Cervical cancer was the most common overall and breast cancer was the most common NADC among HIV infected patients. In our single center cohort, ADCs still represent a significant portion of overall cancers among HIV patients. Publication History Article published online: 20 February 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
Zitieren
APA
Kandula, M., Pinninti, R., Ganduri, V., Santa, A., Krishnamohan, M. V. T., Pavan, B., Sanath, K., Nikhil, P., Pallavi, L., Shah, K., Raveena, G., Rohan, T., Rajappa, S. J., & D., R. R. (2026). Clinical Profile of Patients with Cancer and Human Immuno-Deficiency Infection, Cross-Sectional Observation Study from a Tertiary Care Cancer Center. Indian Journal of Medical and Paediatric Oncology, 47(01), A01-A58. https://doi.org/10.1055/s-0046-1818484
Vancouver
Kandula M, Pinninti R, Ganduri V, Santa A, Krishnamohan MVT, Pavan B, et al. Clinical Profile of Patients with Cancer and Human Immuno-Deficiency Infection, Cross-Sectional Observation Study from a Tertiary Care Cancer Center. Indian Journal of Medical and Paediatric Oncology. 2026;47(01):A01-A58. doi:10.1055/s-0046-1818484
BibTeX
@article{Kandula2026,
author = {Kandula, M. and Pinninti, R. and Ganduri, V. and Santa, A. and Krishnamohan, M. V. T. and Pavan, B. and Sanath, K. and Nikhil, P. and Pallavi, L. and Shah, Kinjal and Raveena, G. and Rohan, T. and Rajappa, S. J. and D., R. Rani},
title = {Clinical Profile of Patients with Cancer and Human Immuno-Deficiency Infection, Cross-Sectional Observation Study from a Tertiary Care Cancer Center},
journal = {Indian Journal of Medical and Paediatric Oncology},
year = {2026},
volume = {47},
number = {01},
pages = {A01--A58},
doi = {10.1055/s-0046-1818484}
}
EUVIMED